The Incubator

Sanford first in the nation to dose patient with SAB’s COVID treatment

A first-of-its-kind approach to targeting COVID-19 has happened between two Sioux Falls-based organizations.

4 years ago

POET, Farmers Business Network partner on new network

Sioux Falls-based POET and Farmers Business Network, which has a large office in the city, are working together on a new network.

4 years ago

Avera chosen as site for experimental COVID-19 antibody trials

Avera Health will be part of three phase two and three clinical trials evaluating whether a combination of two lab-made antibodies can not only treat, but also prevent SARS-CoV-2, the virus that causes COVID-19.

4 years ago

Young entrepreneur awarded $100,000 grant to pursue startup

He watched his dad work long hours on the farm and thought there had to be a better way. Now, at 26, he’s a record-setting entrepreneur in South Dakota.

4 years ago

One to watch: New graduate blends bioscience beginnings with passion for making a difference

4 years ago

Avera cancer research leader sees opportunities to bring ‘exciting new treatment options’

Avera’s cancer research has a new leader with a big vision to bring new trials and treatments to the region.

4 years ago

SAB doses first patient with COVID-19 therapeutic

Sioux Falls-based SAB Biotherapeutics has started testing in a human patient for its therapeutic specifically developed for the virus that causes COVID-19.

4 years ago

SAB announces government funding, private investment for COVID-19 therapeutic and scaling antibody program

Sioux Falls-based SAB Biotherapeutics has received an additional $35.6 million in government funding, plus $14 million in series B funding that includes a new investor – global health care leader Merck.

4 years ago

Maximizing Excellence marks 10 years of business success

This team takes on the tough but valuable work of helping organizations fundraise – with impressive results.

4 years ago

Sanford Research launches COVID-19 antibody study

A new study from Sanford Research will try to determine the prevalence of COVID-19 and learn more about its antibodies.

4 years ago

News Tip

Have a business news item to share with us?

Scroll to top